What's Happening?
Peritia, a global biopharmaceutical and medtech consulting company, has appointed Michael A. Griffith as its new Chief Executive Officer. Griffith brings over 25 years of experience in executive leadership within the biopharma industry, having previously
founded Amplity Health and served in various leadership roles at Altamont Capital Partners and inVentiv Health. His appointment marks a significant milestone for Peritia as it aims to scale its operations and enhance its service offerings in clinical development and value generation.
Why It's Important?
Griffith's appointment is poised to accelerate Peritia's growth and strengthen its position in the biopharmaceutical consulting sector. His extensive experience in building and scaling global pharmaceutical services businesses will be instrumental in expanding Peritia's reach and capabilities. This move reflects the company's commitment to providing strategic advisory and operational support to biotech, pharma, and medtech innovators, potentially leading to more efficient and effective delivery of healthcare innovations to patients.
What's Next?
Under Griffith's leadership, Peritia is expected to focus on scaling its enterprise and enhancing its service offerings. The company may pursue strategic partnerships and investments to expand its capabilities and client base. Stakeholders in the life sciences industry will be watching closely to see how Peritia leverages Griffith's expertise to navigate the evolving landscape of biopharmaceutical consulting.
